Log In
Print this Print this

Solodyn, minocycline

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionExtended-release minocycline hydrocholoride
Molecular Target Ribosomal 30S subunit
Mechanism of ActionRibosomal 30S subunit inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat moderate to severe acne vulgaris
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today